VANGUARD GROUP INC - 31 Mar 2025 SCHEDULE 13G/A Report for Alnylam Pharmaceuticals Inc Common Stock (ALNY)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Alnylam Pharmaceuticals Inc Common Stock
Symbol: ALNY
Shares outstanding: 130,175,523 shares
Disclosed Ownership: 13,056,605 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 07 Apr 2025, 11:51:33 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	10.03%	13,056,605	0	100,382	Ashley Grim	Head of Global Fund Administration